PON1 and prostate cancer: Similarly, the PON1 192Q allele has been reported to reduce the risk of bladder cancer [30], ovarian cancer [31], and B-cell lymphoma [32]; in contrast, it has been reported to increase the risk of lung [19], breast [33] and prostate cancers [34].